NCT06722365 Characterization of Fetal Lung With Quantitative Ultrasound
| NCT ID | NCT06722365 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Wisconsin, Madison |
| Condition | Respiratory Complication |
| Study Type | OBSERVATIONAL |
| Enrollment | 16 participants |
| Start Date | 2024-12-17 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 16 participants in total. It began in 2024-12-17 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to show if it's possible to use a special kind of ultrasound called backscatter quantitative ultrasound (bQUS) to check on a baby's lungs when the mother is 36 weeks pregnant. 16 participants will be on study for a single 30 minute ultrasound between 32 and 36 weeks of pregnancy.
Eligibility Criteria
Inclusion Criteria: * Pregnant females ages 18 to 45 years old with singleton pregnancy, live fetus, gestational age between 32.1 and 36.7 weeks, not in labor, scheduled for routine ultrasound growth evaluation. * Gestational age determined by the date of the last menses, and confirmed by measurement of the crown-rump-length on transabdominal ultrasound. Exclusion Criteria: * Subjects unable to consent * Active Labor * Fetal malformations of the lungs * Prescription of corticosteroids prior to ultrasound evaluation * Pre-gestation or gestational diabetes mellitus * Low English proficiency, needing an interpreter
Contact & Investigator
J. Igor Iruretagoyena, MD, MS
PRINCIPAL INVESTIGATOR
UW School of Medicine and Public Health
Frequently Asked Questions
Who can join the NCT06722365 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Respiratory Complication. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06722365 currently recruiting?
Yes, NCT06722365 is actively recruiting participants. Contact the research team at research.crc_obgyn@wisc.edu for enrollment information.
Where is the NCT06722365 trial being conducted?
This trial is being conducted at Madison, United States.
Who is sponsoring the NCT06722365 clinical trial?
NCT06722365 is sponsored by University of Wisconsin, Madison. The principal investigator is J. Igor Iruretagoyena, MD, MS at UW School of Medicine and Public Health. The trial plans to enroll 16 participants.